All In Biotech

Drug Trial Radar · NCT03218917

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study

Last checked: Nov 19, 2026Latest source record: Mar 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 256 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

256

Actual

Start

Oct 31, 2017

Primary completion

Dec 12, 2019

Study completion Dec 12, 2019

Sponsor

Lead sponsor
Insmed IncorporatedIndustry
Sponsor type
Industry
First posted
Jul 17, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate if INS1007 can reduce pulmonary exacerbations over a 24-week treatment period in participants with non-cystic fibrosis bronchiectasis.

Conditions

  • Non-Cystic Fibrosis Bronchiectasis

Interventions

  • Brensocatib 10 mgDrug

    Administered once per day for 24 weeks

  • Brensocatib 25 mgDrug

    Administered once per day for 24 weeks

  • PlaceboDrug

    Administered once per day for 24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to the First Pulmonary Exacerbation Over 24-Week Treatment PeriodTime frame: Baseline (Day 1) to Week 24

Locations

108 sites in 14 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Phoenix Medical Group

    Peoria, Arizona

  • NewportNativeMD

    Newport Beach, California

  • Palmtree Clinical Research

    Palm Springs, California

  • UC Davis Medical Center

    Sacramento, California

  • Stanford University Medical Center

    Stanford, California

  • National Jewish Heath

    Denver, Colorado

  • UConn Health Center

    Farmington, Connecticut

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Clinical Research Specialists, LLC

    Celebration, Florida

  • St. Francis Medical Institute

    Clearwater, Florida

  • University of Florida

    Gainesville, Florida

  • University of Miami Miller School of Medicine

    Miami, Florida

  • San Marcus Research Clinic, Inc.

    Miami Lakes, Florida

  • Sarasota Memorial Hospital Clinical Research Center

    Sarasota, Florida

  • The Emory Clinic, Pulmonology

    Atlanta, Georgia

  • University of Chicago

    Chicago, Illinois

  • University of Iowa

    Iowa City, Iowa

  • LSU Health Sciences Center

    New Orleans, Louisiana

  • Johns Hopkins University, Division of Pulmonary and Critical Care Medicine

    Baltimore, Maryland

  • Pulmonary and Critical Care Associates of Baltimore

    Towson, Maryland

  • Mid Atlantic Pulmonary & Research Center

    Westminster, Maryland

  • Michigan Medicine

    Ann Arbor, Michigan

  • NYU Pulmonary & Critical Care Associates

    New York, New York

  • Columbia University Medical Center/ New York Presbyterian Hospital

    New York, New York

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Novant Health Pulmonary Medicine South

    Charlotte, North Carolina

  • Southeastern Research Center

    Winston-Salem, North Carolina

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Temple University Hospital

    Philadelphia, Pennsylvania

  • SMS Clinical Research, LLC

    Mesquite, Texas

  • The University of Texas Health Science at Tyler

    Tyler, Texas

  • MultiCare Institute for Research & Innovation

    Tacoma, Washington

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia

  • Mater Misericordia Medical Centre

    Brisbane, Queensland, Australia

  • Gallipoli Medical Research Foundation

    Brisbane, Queensland, Australia

  • Metro North Hospital and Health Service (The Prince Charles Hospital)

    Chermside, Queensland, Australia

Showing 40 of 108 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.